Provided herein are compounds of the formula (1):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
d-Orbital Resonance. III. Deuterium Exchange in Methyl “Onium” Salts and in Bicyclo [2.2.1]heptane-1-sulfonium Iodide<sup>1</sup>
作者:W. von E. Doering、A. Kentaro Hoffmann
DOI:10.1021/ja01608a003
日期:1955.2.1
SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES
申请人:Grünenthal GmbH
公开号:EP3169666B1
公开(公告)日:2018-06-06
Substituted Azaspiro(4.5)Decane Derivatives
申请人:Gruenenthal GmbH
公开号:US20170210734A1
公开(公告)日:2017-07-27
The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the μ opioid receptor and/or the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.